Trinity Biotech plc (TRIB)
USD 0.85
(6.99%)
USD 0.85
(6.99%)
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2023 | 19.93 Million USD | -11.42% |
| 2022 | 22.5 Million USD | -22.73% |
| 2021 | 29.12 Million USD | -3.63% |
| 2020 | 30.21 Million USD | -5.63% |
| 2019 | 32.02 Million USD | 5.47% |
| 2018 | 30.35 Million USD | -7.46% |
| 2017 | 32.8 Million USD | 0.66% |
| 2016 | 32.58 Million USD | -7.22% |
| 2015 | 35.12 Million USD | 4.8% |
| 2014 | 33.51 Million USD | 12.97% |
| 2013 | 29.67 Million USD | 42.94% |
| 2012 | 20.75 Million USD | 4.63% |
| 2011 | 19.83 Million USD | 12.87% |
| 2010 | 17.57 Million USD | -55.16% |
| 2009 | 39.19 Million USD | -7.37% |
| 2008 | 42.31 Million USD | -4.73% |
| 2007 | 44.42 Million USD | -2.53% |
| 2006 | 45.57 Million USD | 25.03% |
| 2005 | 36.45 Million USD | -2.85% |
| 2004 | 37.51 Million USD | 22.79% |
| 2003 | 30.55 Million USD | 50.05% |
| 2002 | 20.36 Million USD | 24.6% |
| 2001 | 16.34 Million USD | 13.39% |
| 2000 | 14.41 Million USD | 51.54% |
| 1999 | 9.51 Million USD | -4.89% |
| 1998 | 10 Million USD | 170.27% |
| 1997 | 3.7 Million USD | 640.0% |
| 1996 | 500 Thousand USD | 66.67% |
| 1995 | 300 Thousand USD | 0.0% |
| 1994 | 300 Thousand USD | -25.0% |
| 1993 | 400 Thousand USD | 0.0% |
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2024 Q2 | 22.95 Million USD | 1.37% |
| 2024 Q1 | 22.64 Million USD | 13.61% |
| 2023 Q1 | 21.53 Million USD | -4.31% |
| 2023 FY | 19.93 Million USD | -11.42% |
| 2023 Q4 | 19.93 Million USD | -4.54% |
| 2023 Q3 | 20.88 Million USD | -7.55% |
| 2023 Q2 | 22.58 Million USD | 4.89% |
| 2022 Q3 | 23.55 Million USD | -19.09% |
| 2022 Q2 | 29.1 Million USD | -1.75% |
| 2022 Q4 | 22.5 Million USD | -4.46% |
| 2022 FY | 22.5 Million USD | -22.73% |
| 2022 Q1 | 29.62 Million USD | 1.73% |
| 2021 Q1 | 37.58 Million USD | 24.37% |
| 2021 Q3 | 32.11 Million USD | -7.46% |
| 2021 Q4 | 29.12 Million USD | -9.32% |
| 2021 FY | 29.12 Million USD | -3.63% |
| 2021 Q2 | 34.7 Million USD | -7.66% |
| 2020 Q3 | 29.6 Million USD | -5.93% |
| 2020 Q1 | 32.67 Million USD | 2.03% |
| 2020 FY | 30.21 Million USD | -5.63% |
| 2020 Q2 | 31.47 Million USD | -3.67% |
| 2020 Q4 | 30.21 Million USD | 2.07% |
| 2019 FY | 32.02 Million USD | 5.47% |
| 2019 Q4 | 32.02 Million USD | 6.88% |
| 2019 Q3 | 29.96 Million USD | -4.85% |
| 2019 Q2 | 31.48 Million USD | 1.76% |
| 2019 Q1 | 30.94 Million USD | 1.92% |
| 2018 Q1 | 34.17 Million USD | 4.19% |
| 2018 Q2 | 34.81 Million USD | 1.87% |
| 2018 Q3 | 32.88 Million USD | -5.54% |
| 2018 Q4 | 30.35 Million USD | -7.69% |
| 2018 FY | 30.35 Million USD | -7.46% |
| 2017 Q1 | 32.65 Million USD | 0.21% |
| 2017 Q4 | 32.8 Million USD | 0.29% |
| 2017 Q2 | 33.62 Million USD | 2.94% |
| 2017 Q3 | 32.71 Million USD | -2.7% |
| 2017 FY | 32.8 Million USD | 0.66% |
| 2016 Q4 | 32.58 Million USD | -18.51% |
| 2016 Q1 | 35.7 Million USD | 1.66% |
| 2016 Q2 | 39.25 Million USD | 9.92% |
| 2016 Q3 | 39.98 Million USD | 1.88% |
| 2016 FY | 32.58 Million USD | -7.22% |
| 2015 Q1 | 37.06 Million USD | 10.58% |
| 2015 Q4 | 35.12 Million USD | -4.76% |
| 2015 FY | 35.12 Million USD | 4.8% |
| 2015 Q3 | 36.88 Million USD | -3.43% |
| 2015 Q2 | 38.19 Million USD | 3.05% |
| 2014 Q3 | 33.77 Million USD | 2.02% |
| 2014 Q1 | 30.86 Million USD | 4.02% |
| 2014 FY | 33.51 Million USD | 12.97% |
| 2014 Q2 | 33.1 Million USD | 7.27% |
| 2014 Q4 | 33.51 Million USD | -0.78% |
| 2013 Q1 | 23.11 Million USD | 11.34% |
| 2013 Q2 | 22.92 Million USD | -0.81% |
| 2013 FY | 29.67 Million USD | 42.94% |
| 2013 Q3 | 27.38 Million USD | 19.47% |
| 2013 Q4 | 29.67 Million USD | 8.34% |
| 2012 Q3 | 21.42 Million USD | 3.04% |
| 2012 Q4 | 20.75 Million USD | -3.13% |
| 2012 Q1 | 19.3 Million USD | -2.71% |
| 2012 Q2 | 20.79 Million USD | 7.74% |
| 2012 FY | 20.75 Million USD | 4.63% |
| 2011 Q2 | 18.97 Million USD | 1.8% |
| 2011 Q1 | 18.63 Million USD | 6.03% |
| 2011 Q4 | 19.83 Million USD | 1.85% |
| 2011 Q3 | 19.47 Million USD | 2.67% |
| 2011 FY | 19.83 Million USD | 12.87% |
| 2010 Q2 | 18.06 Million USD | -54.88% |
| 2010 Q1 | 40.03 Million USD | 2.13% |
| 2010 FY | 17.57 Million USD | -55.16% |
| 2010 Q4 | 17.57 Million USD | -6.3% |
| 2010 Q3 | 18.75 Million USD | 3.84% |
| 2009 Q4 | 39.19 Million USD | -4.98% |
| 2009 Q3 | 41.25 Million USD | -0.99% |
| 2009 FY | 39.19 Million USD | -7.37% |
| 2009 Q2 | 41.66 Million USD | 1.67% |
| 2009 Q1 | 40.98 Million USD | -3.15% |
| 2008 FY | 42.31 Million USD | -4.73% |
| 2008 Q3 | 42.64 Million USD | 0.67% |
| 2008 Q4 | 42.31 Million USD | -0.78% |
| 2008 Q2 | 42.36 Million USD | -1.66% |
| 2008 Q1 | 43.08 Million USD | -3.01% |
| 2007 Q4 | 44.42 Million USD | 0.0% |
| 2007 Q2 | 52.21 Million USD | 6.24% |
| 2007 FY | 44.42 Million USD | -2.53% |
| 2007 Q1 | 49.15 Million USD | 7.86% |
| 2006 Q1 | 38.27 Million USD | 4.99% |
| 2006 FY | 45.57 Million USD | 25.03% |
| 2006 Q4 | 45.57 Million USD | 9.57% |
| 2006 Q3 | 41.59 Million USD | 10.49% |
| 2006 Q2 | 37.64 Million USD | -1.64% |
| 2005 FY | 36.45 Million USD | -2.85% |
| 2005 Q2 | 35.98 Million USD | -2.42% |
| 2005 Q1 | 36.87 Million USD | -1.72% |
| 2005 Q4 | 36.45 Million USD | -5.64% |
| 2005 Q3 | 38.62 Million USD | 7.35% |
| 2004 FY | 37.51 Million USD | 22.79% |
| 2004 Q4 | 37.51 Million USD | -1.94% |
| 2004 Q3 | 38.26 Million USD | 4.65% |
| 2004 Q2 | 36.56 Million USD | 10.01% |
| 2004 Q1 | 33.23 Million USD | 8.77% |
| 2003 Q1 | 22.97 Million USD | 12.85% |
| 2003 Q2 | 22.77 Million USD | -0.87% |
| 2003 FY | 30.55 Million USD | 50.05% |
| 2003 Q3 | 24.76 Million USD | 8.72% |
| 2003 Q4 | 30.55 Million USD | 23.38% |
| 2002 Q3 | 17.36 Million USD | -0.74% |
| 2002 Q2 | 17.49 Million USD | 6.28% |
| 2002 Q4 | 20.36 Million USD | 17.29% |
| 2002 Q1 | 16.45 Million USD | 0.7% |
| 2002 FY | 20.36 Million USD | 24.6% |
| 2001 Q2 | 16.31 Million USD | 7.36% |
| 2001 Q1 | 15.19 Million USD | 5.44% |
| 2001 Q4 | 16.34 Million USD | 2.36% |
| 2001 FY | 16.34 Million USD | 13.39% |
| 2001 Q3 | 15.96 Million USD | -2.14% |
| 2000 Q1 | 10.2 Million USD | 7.27% |
| 2000 FY | 14.41 Million USD | 51.54% |
| 2000 Q4 | 14.41 Million USD | 34.96% |
| 2000 Q2 | 10.24 Million USD | 0.37% |
| 2000 Q3 | 10.67 Million USD | 4.29% |
| 1999 Q4 | 9.51 Million USD | -2.95% |
| 1999 Q3 | 9.8 Million USD | -6.67% |
| 1999 Q2 | 10.5 Million USD | 8.25% |
| 1999 Q1 | 9.7 Million USD | -3.0% |
| 1999 FY | 9.51 Million USD | -4.89% |
| 1998 Q3 | 11.6 Million USD | 114.81% |
| 1998 Q4 | 10 Million USD | -13.79% |
| 1998 Q2 | 5.4 Million USD | 0.0% |
| 1998 FY | 10 Million USD | 170.27% |
| 1997 FY | 3.7 Million USD | 640.0% |
| 1997 Q4 | 3.7 Million USD | 0.0% |
| 1996 Q4 | 500 Thousand USD | 0.0% |
| 1996 FY | 500 Thousand USD | 66.67% |
| 1995 Q4 | 300 Thousand USD | 0.0% |
| 1995 FY | 300 Thousand USD | 0.0% |
| 1994 FY | 300 Thousand USD | -25.0% |
| 1994 Q1 | 400 Thousand USD | 0.0% |
| 1993 FY | 400 Thousand USD | 0.0% |
| Name | Inventory | Inventory Difference |
|---|---|---|
| Aclaris Therapeutics, Inc. | - USD | -Infinity% |
| Biodesix, Inc. | 1.4 Million USD | -1323.786% |
| bioAffinity Technologies, Inc. | 18.48 Thousand USD | -107739.212% |
| Castle Biosciences, Inc. | 7.94 Million USD | -150.982% |
| DarioHealth Corp. | 5.06 Million USD | -293.777% |
| Exact Sciences Corporation | 127.47 Million USD | 84.363% |
| IDEXX Laboratories, Inc. | 380.28 Million USD | 94.758% |
| Illumina, Inc. | 587 Million USD | 96.604% |
| Intelligent Bio Solutions Inc. | 777.53 Thousand USD | -2463.608% |
| iSpecimen Inc. | - USD | -Infinity% |
| Standard BioTools Inc. | 20.53 Million USD | 2.922% |
| 23andMe Holding Co. | 12.46 Million USD | -59.912% |
| Medpace Holdings, Inc. | 1.00 USD | -1993299900.0% |
| NeoGenomics, Inc. | 24.15 Million USD | 17.482% |
| Inotiv, Inc. | 56.1 Million USD | 64.47% |
| Psychemedics Corporation | 1.00 USD | -1993299900.0% |
| Prenetics Global Limited | 3.12 Million USD | -537.494% |
| Precipio, Inc. | 384 Thousand USD | -5090.885% |
| RadNet, Inc. | 1.00 USD | -1993299900.0% |
| Sotera Health Company | 51.98 Million USD | 61.656% |
| Star Equity Holdings, Inc. | 3.42 Million USD | -482.836% |
| Exagen Inc. | 2.87 Million USD | -594.288% |
| Natera, Inc. | 40.75 Million USD | 51.095% |
| Aspira Women's Health Inc. | 227 Thousand USD | -8681.057% |
| Neogen Corporation | 189.26 Million USD | 89.468% |
| Myriad Genetics, Inc. | 20.1 Million USD | 0.831% |
| ICON Public Limited Company | 1.00 USD | -1993299900.0% |
| Bionano Genomics, Inc. | 22.89 Million USD | 12.93% |
| CareDx, Inc | 19.47 Million USD | -2.373% |
| Check-Cap Ltd. | - USD | -Infinity% |
| Twist Bioscience Corporation | 32.06 Million USD | 37.832% |
| Guardant Health, Inc. | 61.94 Million USD | 67.823% |
| BioNexus Gene Lab Corp. | 1.13 Million USD | -1651.936% |
| Fulgent Genetics, Inc. | 5.82 Million USD | -242.08% |
| Sera Prognostics, Inc. | - USD | -Infinity% |
| OPKO Health, Inc. | 65.69 Million USD | 69.659% |
| Personalis, Inc. | 5.66 Million USD | -252.111% |
| Applied DNA Sciences, Inc. | 330.02 Thousand USD | -5939.809% |
| Star Equity Holdings, Inc. | 3.42 Million USD | -482.836% |
| MDxHealth SA | 2.77 Million USD | -617.272% |
| Prenetics Global Limited | 3.12 Million USD | -537.494% |
| ENDRA Life Sciences Inc. | 2.62 Million USD | -659.97% |
| Mainz Biomed B.V. | 613.63 Thousand USD | -3148.332% |
| Neuronetics, Inc. | 8.09 Million USD | -146.299% |
| bioAffinity Technologies, Inc. | 18.48 Thousand USD | -107739.212% |